This episode currently has no reviews.
Submit ReviewMillions of Americans with medical conditions spend years waiting for breakthrough treatments. Today's guest is making extraordinary advances in cancer treatment to significantly improve outcomes.
Today we're sitting down with Dr. Marc Hedrick, President and CEO at Plus Therapeutics whose stock trades under the symbol PSTV. Previously, Dr. Hedrick served in a number of executive leadership roles, including President, CEO and Director of Cytori Therapeutics, and President and CEO of STEM Source. He's a trained general vascular and plastic surgeon, and former Associate Professor of Surgery and Pediatrics at UCLA. He also served as co-Director of the Laboratory of Regenerative Bioengineering and Repair at UCLA.
Dr. Hedrick received his MD from University of Texas Southwestern Medical School Dallas, and an MBA from the Anderson School at UCLA in 2005. We talked about his company's incredible new technology that is revolutionizing how some cancers can be treated.
Highlights:
Links:
Feedback:
If you have questions about the show, or have a topic in mind you'd like discussed in future episodes, email our producer, marion@lowerstreet.co.
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review